Myriad Genetics, Inc. (NASDAQ:MYGN) Q2 2020 Earnings Conference Call February 6, 2020 4:30 PM ET Company Participants Scott Gleason - Vice President-Investor Relations Bryan Riggsbee - Interim President and Chief Executive Officer Conference Call Participants Bill Quirk - Piper Jaffray Doug Schenkel - Cowen and Company Tycho Peterson - JPMorgan Sung Ji Nam - BTIG, LLC Ivy Ma - Bank of America Puneet Souda - SVB Leerink Jack Meehan - Barclays Operator Greetings, and welcome to the Myriad Genetics Second Quar ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 0-26642 MYRIAD GENETICS, INC. (Exact name of registrant as specified in its charter) Delaware 87-0494517 (State or other jurisd ...

Myriad Genetics, Inc. (NASDAQ:MYGN) Q1 2020 Earnings Conference Call November 4, 2019 4:30 PM ET Company Participants Scott Gleason – Vice President-Investor Relations Mark Capone – President and Chief Executive Officer Bryan Riggsbee – Chief Financial Officer Conference Call Participants Tycho Peterson – JPMorgan Puneet Souda – SVB Leerink Bill Quirk – Piper Jaffray Derik de Bruin – Bank of America Adam Wieschhaus – Cowen and Company, LLC Jack Meehan – Barclays Operator Greetings, and welcome to the Myriad ...

Myriad Genetics, Inc. (NASDAQ:MYGN) Q4 2019 Earnings Conference Call August 13, 2019 4:30 PM ET Company Participants Scott Gleason - Head of Investor Relations & Corporate Strategy Mark Capone - President & Chief Executive Officer Bryan Riggsbee - Chief Financial Officer Conference Call Participants Sung Ji Nam - BTIG Patrick Donnelly - Goldman Sachs Bill Quirk - Piper Jaffray Dan Leonard - Deutsche Bank Puneet Souda - SVB Leerink Partners Ivy Ma - Bank of America Merrill Lynch Steve Unger - Needham Tycho P ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | |-------------------------------------------------------------------------|---------------|-------- ...

Call Start: 16:30 January 1, 0000 5:21 PM ET Myriad Genetics, Inc. (NASDAQ:MYGN) Q3 2019 Earnings Conference Call May 7, 2019 16:30 ET Corporate Participants Scott Gleason - Vice President of Investor Relations Mark Capone - President and Chief Executive Officer Bryan Riggsbee - Chief Financial Officer Conference Call Participants Bill Quirk - Piper Jaffray Patrick Donnelly - Goldman Sachs Tycho Peterson - JPMorgan Ivy Ma - Bank of America Merrill Lynch Jack Meehan - Barclays Operator Greetings and welcome ...